BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND PBRM1, BAF180, 55193, PB1, MGC156156, MGC156155 AND Treatment
4 results:

  • 1. Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma.
    Sellner F; Compérat E; Klimpfinger M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003482
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer.
    Sivapalan L; Thorn GJ; Gadaleta E; Kocher HM; Ross-Adams H; Chelala C
    BMC Cancer; 2022 Apr; 22(1):369. PubMed ID: 35392854
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer.
    Botta GP; Kato S; Patel H; Fanta P; Lee S; Okamura R; Kurzrock R
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375311
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pancreatic tropism of metastatic renal cell carcinoma.
    Singla N; Xie Z; Zhang Z; Gao M; Yousuf Q; Onabolu O; McKenzie T; Tcheuyap VT; Ma Y; Choi J; McKay R; Christie A; Torras OR; Bowman IA; Margulis V; Pedrosa I; Przybycin C; Wang T; Kapur P; Rini B; Brugarolas J
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271170
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.